Fighting to Stop Tuberculosis

Researchers at the University of Notre Dame are Fighting to discover compounds and develop drugs to treat neglected diseases that affect billions of the world’s most vulnerable people.

This is why we study organic chemistry. This is why we do research. Every 20 seconds, someone dies from tuberculosis (TB), yet it’s been over 40 years since a new TB drug has been approved for use. Why? Because doing so wasn’t viewed as economically viable. Tell that to the more than two billion people—mostly the developing world’s sick and poor—infected with the bacterium that causes TB, a bacterium that is becoming increasingly drug-resistant to current treatments.

Read more here.

About the Series:

The University of Notre Dame’s award-winning “What Would You Fight For?” series showcases the work, scholarly achievements, and global impact of Notre Dame faculty, students, and alumni. These two-minute segments, each originally aired during a home football game broadcast on NBC, highlight the University’s proud moniker, the Fighting Irish, and tell the stories of the members of the Notre Dame family who fight to bring solutions to a world in need.

Learn More

November 3, 2012

Global AffairsHealth and SocietyScience and TechnologyBiological SciencesChemistry and BiochemistryCollege of ScienceDiseaseGlobal AffairsJeffrey SchoreyMarvin MillerMedicineTuberculosis